ACM
CALC icon

Asymmetry Capital Management’s CalciMedica CALC Stock Holding History

Asymmetry Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,583
Closed -$1.17M – 35
2020
Q3 		$1.17M Buy
+6,583
New +$1.37M 0.75% 30

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Asymmetry Capital Management's CALC Position: Q4 2020 in Review

Asymmetry Capital Management sold out of CalciMedica (CALC) in Q4 2020, closing a stake of 6,583 shares — an estimated $1.17M sold.

Asymmetry Capital Management first reported a position in CALC in Q3 2020 and held it in 1 quarter. The position peaked at $1.17M in Q3 2020. 33 funds tracked by Wall St. Rank hold CALC as of Q4 2020.

  • Asymmetry Capital Management reported no remaining CalciMedica position as of Q4 2020 after selling out during the quarter.
  • Asymmetry Capital Management sold 6,583 CalciMedica shares in Q4 2020, an estimated $1.17M.
  • Asymmetry Capital Management first reported a position in CalciMedica in Q3 2020 and held it in 1 quarter.
  • Asymmetry Capital Management's CalciMedica position peaked at $1.17M in Q3 2020.
  • 33 funds tracked by Wall St. Rank held CalciMedica as of Q4 2020.

Based on Asymmetry Capital Management's 13F filing for Q4 2020, filed 11 Feb 2021.